Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity
Open accessAbstract
Rett syndrome (RTT) is an autism spectrum disorder caused by loss-of-function mutations in the gene encoding MeCP2, an epigenetic modulator that binds the methyl CpG dinucleotide in target genes to regulate transcription. Previously, we and others reported a role of microglia in the pathophysiology of RTT. To understand the mechanism of microglia dysfunction in RTT, we identified a MeCP2 target gene, SLC38A1, which encodes a major glutamine transporter (SNAT1), and characterized its role in microglia. We found that MeCP2 acts as a microglia-specific transcriptional repressor of SNAT1. Because glutamine is mainly metabolized in the mitochondria, where it is used as an energy substrate and a precursor for glutamate production, we hypothesize that SNAT1 overexpression in MeCP2-deficient microglia would impair the glutamine homeostasis, resulting in mitochondrial dysfunction as well as microglial neurotoxicity because of glutamate overproduction. Supporting this hypothesis, we found that MeCP2 downregulation or SNAT1 overexpression in microglia resulted in (1) glutamine-dependent decrease in microglial viability, which was corroborated by reduced microglia counts in the brains of MECP2 knock-out mice; (2) proliferation of mitochondria and enhanced mitochondrial production of reactive oxygen species; (3) increased oxygen consumption but decreased ATP production (an energy-wasting state); and (4) overproduction of glutamate that caused NMDA receptor-dependent neurotoxicity. The abnormalities could be rectified by mitochondria-targeted expression of catalase and a mitochondria-targeted peptide antioxidant, Szeto-Schiller 31. Our results reveal a novel mechanism via which MeCP2 regulates bioenergetic pathways in microglia and suggest a therapeutic potential of mitochondria-targeted antioxidants for RTT.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MECP2 acts as a microglia-specific transcriptional repressor of SNAT1, a major glutamate transporter.
“MECP2 acts as a microglia-specific transcriptional repressor of SNAT1, a major glutamate transporter.”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [40]
MECP2-deficient microglia have impaired glutamate synthesis and mitochondrial function.
“MECP2-deficient microglia have impaired glutamate synthesis and mitochondria function [40].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,949 · see citing works
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1× · see citing works
“Microglia regulate neurodevelopment by actively surveilling and responding to brain microenvironments (Davalos et al., 2005; Nimmerjahn et al., 2005; Tremblay et al., 2010; Paolicelli et al., 2011; Schafer et al., 2012) and could be strongly influenced by epigenetic mechanisms.”
BackgroundRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990 · see citing works
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1× · see citing works
“Microglia regulate neurodevelopment by actively surveilling and responding to brain microenvironments (Davalos et al., 2005; Nimmerjahn et al., 2005; Tremblay et al., 2010; Paolicelli et al., 2011; Schafer et al., 2012) and could be strongly influenced by epigenetic mechanisms.”
BackgroundMicroglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · cited 1× · see citing works
“Microglia regulate neurodevelopment by actively surveilling and responding to brain microenvironments (Davalos et al., 2005; Nimmerjahn et al., 2005; Tremblay et al., 2010; Paolicelli et al., 2011; Schafer et al., 2012) and could be strongly influenced by epigenetic mechanisms.”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1× · see citing works
“Microglia regulate neurodevelopment by actively surveilling and responding to brain microenvironments (Davalos et al., 2005; Nimmerjahn et al., 2005; Tremblay et al., 2010; Paolicelli et al., 2011; Schafer et al., 2012) and could be strongly influenced by epigenetic mechanisms.”
BackgroundAssessing mitochondrial dysfunction in cells
Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,436 · cited 1× · see citing works
“Cellular oxygen consumption is a specific and informative indicator of mitochondrial function (Rolo et al., 2009; Brand and Nicholls, 2011).”
BackgroundWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · cited 1× · see citing works
“The other possibility is a metabolic reprogramming to favor aerobic glycolysis over oxidative phosphorylation, called the Warburg effect, which is known to be driven by L-Gln catabolism in cancer cells (Wise et al., 2008; Samudio et al., 2009).”
BackgroundMeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823 · cited 1× · see citing works
“MECP2 encodes methylCpG-binding protein 2 (MeCP2), an epigenetic modulator that binds the methyl CpG dinucleotide in target genes to regulate transcription (Amir et al., 1999; Chahrour et al., 2008).”
BackgroundExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724 · cited 4× · see citing works
“, 2013); and (2) mCAT, a plasmid that has been shown to direct the expression of catalase only in the mitochondria (Schriner et al., 2005; Dai et al., 2011).”
BackgroundMethodInfluentialA mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558 · cited 2× · see citing works
“Adrian Bird’s laboratory (Guy et al., 2001) were obtained from The Jackson Laboratory.”
MethodMicroglial interactions with synapses are modulated by visual experience
Tremblay, M.-È., Lowery, R. L., & Majewska, A. K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000527 · Cited by 1,542 · cited 1× · see citing works
“Microglia regulate neurodevelopment by actively surveilling and responding to brain microenvironments (Davalos et al., 2005; Nimmerjahn et al., 2005; Tremblay et al., 2010; Paolicelli et al., 2011; Schafer et al., 2012) and could be strongly influenced by epigenetic mechanisms.”
BackgroundHeterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 871 · cited 1× · see citing works
“To further investigate whether MeCP2 deficiency or SNAT1 overexpression affects the activation status of microglia, we quantified several established markers for the “classical activation” (M1) and “alternative activation” (M2) states by qPCR (Colton, 2009).”
BackgroundZhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782 · cited 2× · see citing works
“To test whether enhanced mtROS production as a result of SNAT1 overexpression leads to mitochondrial dysfunction in microglia, we used two mitochondria-targeted approaches using the following: (1) SS-31, a cell-permeable, mitochondriatargeted peptide antioxidant (Zhao et al., 2004) able to concentrate 1000- to 5000-fo…”
MethodThe oxidative inactivation of mitochondrial electron transport chain components and ATPase.
Zhang, Y., Marcillat, O., Giulivi, C., Ernster, L., & Davies, K. J. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46227-2 · Cited by 713 · cited 1× · see citing works
“Although it is likely that mtROS, especially hydroxyl rad- icals, reduce ATP production by their effects on components of the electron transport chain (Zhang et al., 1990), it remains to be elucidated how mtROS enhance abnormal glutamate production in MDM. Nonetheless, our data indicate that…”
BackgroundWild-type microglia arrest pathology in a mouse model of Rett syndrome
Derecki, N. C., Cronk, J. C., Lu, Z., Xu, E., Abbott, S. B. G., Guyenet, P. G., & Kipnis, J. (2012) · Nature · doi:10.1038/nature10907 · Cited by 607 · cited 4× · see citing works
“We and others previously showed a role of microglial abnormalities in RTT in mouse models (Maezawa and Jin, 2010; Derecki et al., 2012).”
BackgroundInfluentialDecoding the Epigenetic Language of Neuronal Plasticity
Borrelli, E., Nestler, E. J., Allis, C. D., & Sassone‐Corsi, P. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.012 · Cited by 529 · cited 1× · see citing works
“Epigenetic mechanisms play an important role in the brain’s capability to adapt to environmental challenges (Borrelli et al., 2008).”
BackgroundDai, D.-F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., Kang, Y. J., Prolla, T. A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.232306 · Cited by 527 · cited 2× · see citing works
“…in inner mitochondrial membrane and help scavenge hydroxyl radicals and peroxynitrite and possibly HOCl and peroxyl radicals (Gruber et al., 2013); and (2) mCAT, a plasmid that has been shown to direct the expression of catalase only in the mitochondria (Schriner et al., 2005; Dai et al., 2011).”
BackgroundMethodSodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family
Mackenzie, B., & Erickson, J. D. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1117-9 · Cited by 515 · cited 3× · see citing works
“This toxicity was blocked by MeAIB, a paradigm analog inhibitor of system A transporters (Mackenzie and Erickson, 2004), suggesting that the toxicity was mediated by excessive L-Gln uptake.”
BackgroundInfluentialEnergetics, epigenetics, mitochondrial genetics
Wallace, D. C., & Fan, W. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.09.006 · Cited by 507 · cited 2× · see citing works
“One novel mode of such epigenetic influence is bioenergetics (Wallace and Fan, 2010).”
BackgroundMitochondrial oxidative stress in aging and healthspan
Dai, D., Chiao, Y. A., Marcinek, D. J., Szeto, H. H., & Rabinovitch, P. S. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-6 · Cited by 481 · cited 2× · see citing works
“Some such compounds have recently moved into clinical trials and could, in principle, benefit girls with RTT (Gruber et al., 2013; Dai et al., 2014).”
BackgroundMitochondrial dysfunction in autism
Giulivi, C., Zhang, Y.-F., Omanska-Klusek, A., Ross-Inta, C., Wong, S., Hertz-Picciotto, I., Tassone, F., & Pessah, I. N. (2010) · JAMA · doi:10.1001/jama.2010.1706 · Cited by 466 · see citing works
Albrecht, J., & Norenberg, M. D. (2006) · Hepatology · doi:10.1002/hep.21357 · Cited by 455 · cited 1× · see citing works
“At elevated levels, intracellular L-Gln could damage mitochondria via its metabolism in mitochondria to ammonia and glutamate, causing cell toxicity or functional aberrations (Albrecht and Norenberg, 2006).”
BackgroundSamaco, R. C., Hogart, A., & LaSalle, J. M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi045 · Cited by 420 · cited 1× · see citing works
“…gene mutation (Amir et al., 1999; Levitt and Campbell, 2009) and MeCP2 regulation is also abnormal in a large subgroup of autistic individuals (Samaco et al., 2005; Moretti and Zoghbi, 2006; Nagarajan et al., 2008; Levitt and Campbell, 2009; Ramocki et al., 2009), our studies may implicate a…”
ResultSuzumura, A., Mezitis, S., Gonatas, N., & Silberberg, D. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90121-4 · Cited by 349 · cited 1× · see citing works
“Primary microglia cultures were prepared from mixed glia cultures established from newborn mice with the “shaking-off” method as described previously (Suzumura et al., 1987).”
MethodRett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate
Maezawa, I., & Jin, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5966-09.2010 · Cited by 348 · cited 17× · see citing works
“This overproduction could be reduced by restriction of L-Gln in the medium (Maezawa and Jin, 2010).”
BackgroundMethodResultInfluentialSamudio, I. J., Fiegl, M., & Andreeff, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3722 · Cited by 309 · cited 1× · see citing works
“The other possibility is a metabolic reprogramming to favor aerobic glycolysis over oxidative phosphorylation, called the Warburg effect, which is known to be driven by L-Gln catabolism in cancer cells (Wise et al., 2008; Samudio et al., 2009).”
BackgroundRamocki, M. B., Peters, S. U., Tavyev, Y. J., Zhang, F., Carvalho, C. M. B., Schaaf, C. P., Richman, R., Fang, P., Glaze, D. G., Lupski, J. R., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21715 · Cited by 302 · cited 1× · see citing works
“…in a large subgroup of autistic individuals (Samaco et al., 2005; Moretti and Zoghbi, 2006; Nagarajan et al., 2008; Levitt and Campbell, 2009; Ramocki et al., 2009), our studies may implicate a novel mechanism for autism where mitochondrial dysfunction also plays a role (Giulivi et al.,…”
BackgroundCloning and Functional Identification of a Neuronal Glutamine Transporter
Varoqui, H., Yao, D., Zhu, H., Hong, M., & Erickson, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4049 · Cited by 301 · cited 4× · see citing works
“To test whether this is the consequence of SNAT1 overexpression, we transfected BV-2 cells with a SNAT1 expression plasmid vector (Varoqui et al., 2000).”
MethodResultInfluentialMeCP2 dysfunction in Rett syndrome and related disorders
Moretti, P. M., & Zoghbi, H. Y. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.04.009 · Cited by 290 · cited 1× · see citing works
“…et al., 1999; Levitt and Campbell, 2009) and MeCP2 regulation is also abnormal in a large subgroup of autistic individuals (Samaco et al., 2005; Moretti and Zoghbi, 2006; Nagarajan et al., 2008; Levitt and Campbell, 2009; Ramocki et al., 2009), our studies may implicate a novel mechanism for…”
BackgroundCell type–specific DNA methylation at intragenic CpG islands in the immune systemPreprint
Deaton, A. M., Webb, S., Kerr, A. R. W., Illingworth, R. S., Guy, J., Andrews, R., & Bird, A. P. (2011) · Genome Research · doi:10.1101/gr.118703.110 · Cited by 285 · see citing works
Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions
Maezawa, I., Swanberg, S. E., Harvey, D. J., LaSalle, J. M., & Jin, L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0324-09.2009 · Cited by 283 · cited 1× · see citing works
“The astrocyte cultures were prepared from newborn mice as described previously and cultured for 14 d in vitro before being used for experiments (Maezawa et al., 2009).”
MethodBelichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., & Francke, U. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22009 · Cited by 272 · cited 2× · see citing works
“Mice with MECP2 knock-out also show mitochondrial dysfunction in the skeletal muscle (Gold et al., 2014) and abnormal mitochondrial ultrastructure in the dendrite (Belichenko et al., 2009).”
BackgroundHow Do Immune Cells Support and Shape the Brain in Health, Disease, and Aging?
Schwartz, M., Kipnis, J., Rivest, S., & Prat, A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3241-13.2013 · Cited by 256 · cited 1× · see citing works
“However, a MeCP2 deficiency-initiated molecular pathway to account for microglial abnormalities in RTT has not been reported, despite the significant role of microglia in RTT (Maezawa and Jin, 2010; Derecki et al., 2012, 2013; Schwartz et al., 2013).”
BackgroundGlutamate release from activated microglia requires the oxidative burst and lipid peroxidation
Barger, S. W., Goodwin, M. E., Porter, M. M., & Beggs, M. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04487.x · Cited by 255 · cited 2× · see citing works
“…microglia is overproduction of glutamate, to a degree that may cause low levels of neurotoxicity manifested as pruning of synapses and dendrites (Hutchins and Barger, 1998; Barger et al., 2007), clearly shown in our current data and previous studies (Maezawa and Jin, 2010; O’Driscoll et al., 2013).”
BackgroundResultLevitt, P., & Campbell, D. B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37934 · Cited by 234 · cited 2× · see citing works
“…regulation is also abnormal in a large subgroup of autistic individuals (Samaco et al., 2005; Moretti and Zoghbi, 2006; Nagarajan et al., 2008; Levitt and Campbell, 2009; Ramocki et al., 2009), our studies may implicate a novel mechanism for autism where mitochondrial dysfunction also plays a…”
BackgroundGene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome
Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., MacLeod, N., & Bird, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01665-05 · Cited by 219 · cited 2× · see citing works
“…expression studies revealed gene alterations in RTT human and mouse samples (upregulation of ubiquinolcytochrome c reductase core protein 1 and downregulation of cytochrome c oxidase subunit 1) that may lead to mitochondrial respiratory chain defects (Kriaucionis et al., 2006; Gibson et al., 2010).”
BackgroundTang, Z., Gan, Y. X., Liu, Q., Yin, J., Liu, Q., Shi, J., & Shi, F. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-26 · Cited by 192 · cited 2× · see citing works
“AAGGACA-3 /5 -TGAGTAGCAGCCTTGGAATG-3 ; and IGF-I, 5 TGGATGCTCTTCAGTTCGTG-3 /5 -CACAATGCCTGTCTGAGGTG-3 (Lee et al., 2013; Moreno et al., 2014; Tang et al., 2014).”
Glutamine homeostasis and mitochondrial dynamics
Matés, J. M., Segura, J. A., Campos-Sandoval, J. A., Lobo, C., Alonso, L., Alonso, F. J., & Márquez, J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.003 · Cited by 157 · cited 2× · see citing works
“Given that L-Gln taken up by cells is quickly accumulated in mitochondria and hydrolyzed by mitochondrial glutaminase to glutamate (Matés et al., 2009), the upregulation of SNAT1 in MDM may contribute to overproduction of glutamate.”
BackgroundGlutamine as a mediator of ammonia neurotoxicity: A critical appraisal
Albrecht, J., Zielińska, M., & Norenberg, M. D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.024 · Cited by 151 · cited 1× · see citing works
“9), which leads to production of mtROS (Jayakumar et al., 2004; Svoboda and Kerschbaum, 2009; Albrecht et al., 2010).”
BackgroundSystemic oxidative stress in classic Rett syndrome
De Felice, C., Ciccoli, L., Leoncini, S., Signorini, C., Rossi, M., Vannuccini, L., Guazzi, G., Latini, G., Comporti, M., Valacchi, G., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.016 · Cited by 148 · cited 1× · see citing works
“…(Ruch et al., 1989; Wakai et al., 1990; Dotti et al., 1993; Cornford et al., 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased oxidative stress (Sierra et al., 2001; De Felice et al., 2009).”
BackgroundGiordano, S. S., Lee, J., Darley-Usmar, V. M., & Zhang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044610 · Cited by 142 · cited 1× · see citing works
“6A,C,D), a mitochondrial complex I inhibitor (Giordano et al., 2012), suggesting that the L-Gln stimulatory effect was not caused by some extra-mitochondrial action.”
BackgroundGruber, J., Fong, S., Chen, C.-B., Yoong, S. L., Pastorin, G., Schaffer, S., Cheah, I. K.-M., & Halliwell, B. B. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.005 · Cited by 138 · cited 4× · see citing works
“As expected, neither SS-31 nor mCAT reduced MitoSox levels (data not shown) because SS-31 is unlikely to react directly with superoxide (Gruber et al., 2013) and mCAT acts on hydrogen peroxide, downstream of superoxide.”
BackgroundInfluentialLee, D. C., Ruiz, C. R., Lebson, L. A., Selenica, M. B., Rizer, J., Hunt, J. B., Rojiani, R., Reid, P., Kammath, S., Nash, K. R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.014 · Cited by 119 · cited 2× · see citing works
“AAGGACA-3 /5 -TGAGTAGCAGCCTTGGAATG-3 ; and IGF-I, 5 TGGATGCTCTTCAGTTCGTG-3 /5 -CACAATGCCTGTCTGAGGTG-3 (Lee et al., 2013; Moreno et al., 2014; Tang et al., 2014).”
Glutamine‐induced free radical production in cultured astrocytes
Jayakumar, A. R., Rao, K. V. R., Schousboe, A., & Norenberg, M. D. (2004) · Glia · doi:10.1002/glia.20003 · Cited by 117 · cited 1× · see citing works
“9), which leads to production of mtROS (Jayakumar et al., 2004; Svoboda and Kerschbaum, 2009; Albrecht et al., 2010).”
BackgroundMoreno, M. A., Bannerman, P., Ma, J. H., Guo, F., Miers, L., Soulika, A., & Pleasure, D. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1137-14.2014 · Cited by 115 · cited 2× · see citing works
“AAGGACA-3 /5 -TGAGTAGCAGCCTTGGAATG-3 ; and IGF-I, 5 TGGATGCTCTTCAGTTCGTG-3 /5 -CACAATGCCTGTCTGAGGTG-3 (Lee et al., 2013; Moreno et al., 2014; Tang et al., 2014).”
MECP2 promoter methylation and X chromosome inactivation in autism
Nagarajan, R. P., Patzel, K. A., Martin, M. R., Yasui, D. H., Swanberg, S. E., Hertz‐Picciotto, I., Hansen, R. L., de Water, J. V., Pessah, I. N., Jiang, R., et al. (2008) · Autism Research · doi:10.1002/aur.24 · Cited by 110 · cited 1× · see citing works
“…Campbell, 2009) and MeCP2 regulation is also abnormal in a large subgroup of autistic individuals (Samaco et al., 2005; Moretti and Zoghbi, 2006; Nagarajan et al., 2008; Levitt and Campbell, 2009; Ramocki et al., 2009), our studies may implicate a novel mechanism for autism where mitochondrial…”
BackgroundGibson, J. H., Slobedman, B., Kurup, H. K. N., Williamson, S. L., Minchenko, D., El‐Osta, A., Stern, J. L., & Christodoulou, J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-53 · Cited by 101 · cited 2× · see citing works
“…expression studies revealed gene alterations in RTT human and mouse samples (upregulation of ubiquinolcytochrome c reductase core protein 1 and downregulation of cytochrome c oxidase subunit 1) that may lead to mitochondrial respiratory chain defects (Kriaucionis et al., 2006; Gibson et al., 2010).”
BackgroundWhy neurons die: Cell death in the nervous system
Hutchins, J. B., & Barger, S. W. (1998) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199806)253:3 · Cited by 100 · see citing works
The role of microglia in brain maintenance: implications for Rett syndrome
Derecki, N. C., Cronk, J. C., & Kipnis, J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.002 · Cited by 99 · see citing works
Okabe, Y., Takahashi, T., Mitsumasu, C., Kosai, K.-I., Tanaka, E., & Matsuishi, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035354 · Cited by 90 · cited 1× · see citing works
“This elevation could be attributable to increased protein levels of glutamine synthetase, an exclusively astrocytic enzyme, in Mecp2 /y astrocytes (Okabe et al., 2012).”
BackgroundCornford, M. E., Philippart, M., Jacobs, B., Scheibel, A. B., & Vinters, H. V. (1994) · Journal of Child Neurology · doi:10.1177/088307389400900419 · Cited by 90 · cited 1× · see citing works
“Patients with RTT showed abnormal mitochondrial morphology (Ruch et al., 1989; Wakai et al., 1990; Dotti et al., 1993; Cornford et al., 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased…”
BackgroundMeCP2 modulates gene expression pathways in astrocytes
Yasui, D. H., Xu, H., Dunaway, K. W., LaSalle, J. M., Jin, L.-W., & Maezawa, I. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-3 · Cited by 90 · cited 3× · see citing works
“Starting from our recent ChIP-seq data (Yasui et al., 2013), we identified a novel mechanism, illustrated in Figure 9, that coherently links dysregulation of a direct target of MeCP2, SNAT1, to mitochondrial abnormalities.”
BackgroundMethodSelf-citationMaezawa, I., Hong, H., Wu, H., Battina, S. K., Rana, S., Iwamoto, T., Radke, G. A., Pettersson, E., Martin, G. M., Hua, D. H., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03862.x · Cited by 88 · cited 1× · see citing works
“Cell viability was assayed by MTT (tetrazolium salt) as described previously (Maezawa et al., 2006).”
MethodOxidative stress in Rett syndrome
Sierra, C., Vilaseca, M. A., Brandi, N., Artuch, R., Mira, A., Nieto, M., & Pineda, M. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00369-2 · Cited by 79 · cited 2× · see citing works
“…(Ruch et al., 1989; Wakai et al., 1990; Dotti et al., 1993; Cornford et al., 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased oxidative stress (Sierra et al., 2001; De Felice et al., 2009).”
BackgroundGold, W. A., Williamson, S. L., Kaur, S., Hargreaves, I. P., Land, J. M., Pelka, G. J., Tam, P. P. L., & Christodoulou, J. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.02.012 · Cited by 73 · see citing works
Rett Syndrome and Mitochondrial Enzyme Deficiencies
Coker, S. B., & Melnyk, A. R. (1991) · Journal of Child Neurology · doi:10.1177/088307389100600216 · Cited by 65 · cited 2× · see citing works
“, 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased oxidative stress (Sierra et al.”
BackgroundMitochondrial dysfunction in Rett syndrome
Dotti, M. T., Manneschi, L., Malandrini, A., Stefano, N. D., Caznerale, F., & Federico, A. (1993) · Brain and Development · doi:10.1016/0387-7604(93)90045-a · Cited by 61 · cited 2× · see citing works
“Patients with RTT showed abnormal mitochondrial morphology (Ruch et al., 1989; Wakai et al., 1990; Dotti et al., 1993; Cornford et al., 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased…”
BackgroundMitochondrial alterations in Rett syndrome
Ruch, A., Kurczynski, T. W., & Velasco, M. E. (1989) · Pediatric Neurology · doi:10.1016/0887-8994(89)90027-1 · Cited by 60 · cited 2× · see citing works
“Patients with RTT showed abnormal mitochondrial morphology (Ruch et al., 1989; Wakai et al., 1990; Dotti et al., 1993; Cornford et al., 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased…”
BackgroundInfantile hypotonia as a presentation of rett syndrome
Heilstedt, H. A., Shahbazian, M. D., & Lee, B. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10633 · Cited by 53 · cited 2× · see citing works
“, 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased oxidative stress (Sierra et al.”
BackgroundWard, B. C., Kolodny, N. H., Nag, N., & Berger-Sweeney, J. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05768.x · Cited by 53 · cited 1× · see citing works
“Potentially aggravating this vulnerability, NMR microscopy studies revealed elevated cerebral L-Gln levels in Mecp21lox mice (Ward et al., 2009) and glutamine/Cr ratios in RTT girls (Horská et al., 2009).”
BackgroundGrewal, S., Defamie, N., Zhang, X., Gois, S. D., Shawki, A., Mackenzie, B., Chen, C., Varoqui, H., & Erickson, J. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806470200 · Cited by 48 · cited 2× · see citing works
“The well characterized, highly specific polyclonal anti-SNAT1 was described previously (Varoqui et al., 2000; Grewal et al., 2009) and was used in 1:1000 dilution.”
MethodResultRett syndrome: findings suggesting axonopathy and mitochondrial abnormalities
Wakai, S., Kameda, K., Ishikawa, Y., Miyamoto, S., Nagaoka, M., Okabe, M., Minami, R., & Tachi, N. (1990) · Pediatric Neurology · doi:10.1016/0887-8994(90)90028-y · Cited by 48 · cited 2× · see citing works
“Patients with RTT showed abnormal mitochondrial morphology (Ruch et al., 1989; Wakai et al., 1990; Dotti et al., 1993; Cornford et al., 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased…”
BackgroundBrain metabolism in rett syndrome: Age, clinical, and genotype correlations
Horská, A., Farage, L., Bibat, G., Nagae, L. M., Kaufmann, W. E., Barker, P. B., & Naidu, S. (2009) · Annals of Neurology · doi:10.1002/ana.21562 · Cited by 48 · cited 1× · see citing works
“Potentially aggravating this vulnerability, NMR microscopy studies revealed elevated cerebral L-Gln levels in Mecp21lox mice (Ward et al., 2009) and glutamine/Cr ratios in RTT girls (Horská et al., 2009).”
BackgroundClinical recognition of rett syndrome
Philippart, M., Opitz, J. M., & Reynolds, J. F. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320250512 · Cited by 37 · cited 1× · see citing works
“In fact, before the identification of the causative RTT genes, mitochondrial abnormalities were suspected as the cause of RTT (Philippart, 1986).”
BackgroundSchilling, T., & Eder, C. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.070763 · Cited by 36 · cited 1× · see citing works
“System A transporter activities have been well characterized in BV-2 microglia cells (Schilling and Eder, 2004; Van den Eynden et al., 2011).”
BackgroundRett syndrome: Genetic clues based on mitochondrial changes in muscle
Eeg‐Olofsson, O., Al‐Zuhair, A. G. H., Teebi, A. S., Al‐Essa, M., Opitz, J. M., & Reynolds, J. F. (1989) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320320131 · Cited by 32 · cited 2× · see citing works
“…(Ruch et al., 1989; Wakai et al., 1990; Dotti et al., 1993; Cornford et al., 1994), enzymatic defects of the mitochondrial respiratory chain (Eeg-Olofsson et al., 1989; Coker and Melnyk, 1991; Heilstedt et al., 2002), and increased oxidative stress (Sierra et al., 2001; De Felice et al.,…”
Backgroundl ‐Glutamine‐induced apoptosis in microglia is mediated by mitochondrial dysfunction
Svoboda, N., & Kerschbaum, H. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06828.x · Cited by 30 · cited 1× · see citing works
“Primary microglia cultures were prepared from mixed glia cultures established from newborn mice with the “shaking-off” method as described previously (Suzumura et al., 1987).”
MethodMeCP2 deficiency enhances glutamate release through NF-κB signaling in myeloid derived cells
O’Driscoll, C. M., Kaufmann, W. E., & Bressler, J. P. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.002 · Cited by 26 · cited 15× · see citing works
“This result also supports the notion that MDM affects brain function not through assuming any conventionally defined activation state.”
BackgroundResultInfluentialBiosensor plates detect mitochondrial physiological regulators and mutations in vivo
Rolo, A. P., Palmeira, C. M., & Cortopassi, G. A. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.10.002 · Cited by 18 · cited 4× · see citing works
“6A; Rolo et al., 2009).”
BackgroundMethodInfluentialden Eynden, J. V., Notelaers, K., Brône, B., Janssen, D., Nelissen, K., Sahebali, S. S., Smolders, I., Hellings, N., Steels, P., & Rigo, J. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0939-0 · Cited by 8 · cited 1× · see citing works
“System A transporter activities have been well characterized in BV-2 microglia cells (Schilling and Eder, 2004; Van den Eynden et al., 2011).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Microglial metabolic flexibility supports immune surveillance of the brain parenchyma
Bernier, L., York, E. M., Kamyabi, A., Choi, H. B., Weilinger, N. L., & MacVicar, B. A. (2020) · Nature Communications · doi:10.1038/s41467-020-15267-z · Cited by 302 · see citing works
Immunometabolism in the Brain: How Metabolism Shapes Microglial Function
Bernier, L., York, E. M., & MacVicar, B. A. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.08.008 · Cited by 295 · see citing works
Vaz, R. L., Outeiro, T. F., & Ferreira, J. J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00347 · Cited by 169 · see citing works
Schafer, D. P., Heller, C. T., Gunner, G., Heller, M., Gordon, C., Hammond, T., Wolf, Y., Jung, S., & Stevens, B. (2016) · eLife · doi:10.7554/elife.15224 · Cited by 147 · see citing works
“Microglia, the brain resident myeloid-derived cell, are among the most recent cell types implicated in RTT pathogenesis (Derecki et al., 2012; Cronk et al., 2015; Jin et al., 2015; Maezawa and Jin, 2010).”
BackgroundResultInfluentialMetabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches
Cheng, N., Rho, J. M., & Masino, S. A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00034 · Cited by 148 · see citing works
“Jin et al., 2015 Mecp2, whose mutations cause Rett syndrome, was observed to regulate mitochondrial bioenergetics through a glutamine transporter in microglia.”
BackgroundMicroglia antioxidant systems and redox signalling
Vilhardt, F., Haslund-Vinding, J. L., Jaquet, V., & McBean, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13426 · Cited by 133 · see citing works
“…glutamate release that may also be relevant in a pathological context, which include disruption to glutamine metabolism (Maezawa and Lee-Way, 2010; Jin et al., 2015), volume-regulated anion channels (Harrigan et al., 2008) and gap junction hemi-channels (Maezawa and Lee-Way, 2010) that offer…”
BackgroundTranscriptional and Epigenetic Regulation of Microglia in Health and Disease
Yeh, H., & Ikezu, T. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.004 · Cited by 135 · see citing works
Jena, P. K., Sheng, L., Di Lucente, J., Jin, L., Maezawa, I., & Wan, Y. Y. (2018) · The FASEB Journal · doi:10.1096/fj.201700984rr · Cited by 134 · see citing works
“Using this method, 94% of isolated cells are microglial cells, as determined by flow cytometry (26).”
MethodSelf-citationMaezawa, I., Nguyen, H. M., Di Lucente, J., Jenkins, D. P., Singh, V., Hilt, S., Kim, K., Rangaraju, S., Levey, A. I., Wulff, H., et al. (2018) · Brain · doi:10.1093/brain/awx346 · Cited by 125 · see citing works
“Microglia were acutely isolated from adult brains without culturing as described (Jin et al., 2015).”
MethodShulyakova, N., Andreazza, A. C., Mills, L. R., & Eubanks, J. H. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00058 · Cited by 115 · see citing works
“, 2015), and in isolated Mecp2−/y microglia (Jin et al., 2015) provides further evidence that the absence of MeCP2 leads to impaired mitochondrial function.”
BackgroundMartin, E., Behi, M. E., Fontaine, B., & Delarasse, C. (2017) · Journal of Visualized Experiments · doi:10.3791/55781 · Cited by 111 · see citing works
Miao, J., Chen, L., Pan, X., Li, L.-Q., Zhao, B., & Lan, J. X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01376-y · Cited by 110 · see citing works
“Glutamine, a highly abundant amino acid in plasma, has been believed not to cross the BBB freely due to multiple transporters (Jin et al. 2015).”
BackgroundMitochondrial function and abnormalities implicated in the pathogenesis of ASD
Castora, F. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.015 · Cited by 104 · see citing works
Di Lucente, J., Nguyen, H. M., Wulff, H., Jin, L., & Maezawa, I. (2018) · Glia · doi:10.1002/glia.23457 · Cited by 96 · see citing works
“Microglia were isolated using CD11b-based immunopanning as previously described (Bohlen et al., 2017; Jin et al., 2015).”
MethodMicroglia energy metabolism in metabolic disorder
Kalsbeek, M. J. T., Mulder, L., & Yi, C. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.09.028 · Cited by 93 · see citing works
Glutaminase in microglia: A novel regulator of neuroinflammation
Ding, L., Xu, X., Li, C., Wang, Y., Xia, X., & Zheng, J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.11.038 · Cited by 88 · see citing works
“Many studies have demonstrated significant up-regulation of microglial GLS under pathological conditions that include AD, HAND, multiple sclerosis (MS), ALS, Rett syndrome (RTT), and other neurological diseases (Gao et al., 2019; Jin et al., 2015; Tian et al., 2008; Ye et al., 2013).”
BackgroundMetabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Lepiarz-Raba, I., Gbadamosi, I., Florea, R., Paolicelli, R. C., & Jawaid, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00382-w · Cited by 90 · see citing works
“The uptake of glutamine in microglia is conducted via SNAT1 (solute carrier family 38a member 1 protein) [82].”
BackgroundPortugal, C. C., Socodato, R., Canedo, T., Silva, C. M., Martins, T., Miya-Coreixas, V. S., Loiola, E. C., Gess, B., Röhr, D., Santiago, A. R., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal2005 · Cited by 74 · see citing works
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
Jin, L., Lucente, J. D., Nguyen, H. M., Singh, V., Singh, L., Chavez, M., Bushong, T. R., Wulff, H., & Maezawa, I. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.754 · Cited by 75 · see citing works
“The purity of isolated microglia, determined by flow cytometry, was consistently between 94 to 96%.(26) Compared to Wt microglia (Fig.”
BackgroundInhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
Chen, Y., Nguyen, H. M., Maezawa, I., Jin, L., & Wulff, H. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.513 · Cited by 64 · see citing works
“CD11b cells from the infarct area were isolated as previously described.(16,27) Briefly, mice were anesthetized with isoflurane 2, 5, and 8 days after reperfusion MCAO and killed by cervical dislocation.”
MethodZhao, D., Mokhtari, R., Pedrosa, E., Birnbaum, R., Zheng, D., & Lachman, H. M. (2017) · Molecular Autism · doi:10.1186/s13229-017-0134-z · Cited by 63 · see citing works
“, for example, found that an increase in the expression of Slc38a1 (which codes for a glutamine transporter) caused by Mecp2 deficiency results in a glutamine-dependent decrease in microglia viability and a reduction in brain microglial number through the production of reactive oxygen species (ROS), which causes mitoc…”
BackgroundRojas-Charry, L., Nardi, L., Methner, A., & Schmeißer, M. J. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02018-2 · Cited by 59 · see citing works
MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome
Jin, X.-R., Chen, X.-S., & Xiao, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00316 · Cited by 55 · see citing works
“As a consequence, adenosine triphosphate (ATP) production is significantly reduced in MeCP2-deficient microglia, and this ATP reduction leads to a greater potential for the apoptosis of abnormal microglia (Jin et al., 2015) (Figure 2).”
BackgroundInfluentialCompromised immune/inflammatory responses in Rett syndrome
Pecorelli, A., Cervellati, C., Cordone, V., Hayek, J., & Valacchi, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.023 · Cited by 56 · see citing works
“[10] shown that MeCP2 acts as transcriptional repressor for the glutamine transporter SNAT1.”
BackgroundJin, L., Lucente, J. D., Mendiola, U. R., Suthprasertporn, N., Tomilov, A. A., Cortopassi, G. A., Kim, K., Ramsey, J. J., & Maezawa, I. (2023) · The FASEB Journal · doi:10.1096/fj.202301254r · Cited by 52 · see citing works
“6,7 Fatty acids are metabolized by β -ox- idation within the “mitochondrial ketogenic pathway” (MKP) to generate β -hydroxybutyrate (BHB), a ketone body.”
BackgroundGlial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
Kahanovitch, U., Patterson, K. C., Hernandez, R. D., & Olsen, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153813 · Cited by 50 · see citing works
“Snat1 overexpression or Mecp2 KO reduces the number of microglia, causes mitochondrial dysfunction, and results in over-production of glutamate leading to excitotoxicity [105].”
BackgroundNeurobiologically-based treatments in Rett syndrome: opportunities and challenges
Kaufmann, W. E., Stallworth, J. L., Everman, D. B., & Skinner, S. A. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1229181 · Cited by 50 · see citing works
“Although the precise mechanism mediating adverse microglial effects on neurons is still debated [57,58], excessive release of glutamate [59,60] and inflammatory cytokines have been replicated in different studies [61,62].”
BackgroundBebensee, D. F., Can, K., & Müller, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3064016 · Cited by 48 · see citing works
“Interestingly, an increased mitochondrial mass was also reported for Mecp2 microglia of the juvenile mouse brain [78].”
Can, K., Menzfeld, C., Rinne, L., Rehling, P., Kügler, S., Golubiani, G., Dudek, J., & Müller, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00479 · Cited by 46 · see citing works
Zhang, P., Omanska-Klusek, A., Ander, B. P., Gandal, M. J., Stamova, B. S., & Schumann, C. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206758120 · Cited by 46 · see citing works
An mtDNA mutant mouse demonstrates that mitochondrial deficiency can result in autism endophenotypes
Yardeni, T., Cristancho, A. G., McCoy, A. J., Schaefer, P. M., McManus, M. J., Marsh, E. D., & Wallace, D. C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021429118 · Cited by 44 · see citing works
“This is observed in fragile X syndrome (57 – 60), Rett syndrome (61, 62), Angelman syndrome (63 – 65), Phelan-McDermid syndrome (66, 67), and the 22q11 CNV (45).”
Horiuchi, M., Smith, L., Maezawa, I., & Jin, L. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.014 · Cited by 41 · see citing works
“This set of results is consistent with previous findings that the number of microglia in the brain was decreased in Mecp2KO mice (Jin et al., 2015; Cronk et al., 2015b), and indicates that microglia in Mecp2KO mice expressed Cx 3 cr1 at the same level as those in WT mice.”
InfluentialMECP2 and the biology of MECP2 duplication syndrome
D’Mello, S. R. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15331 · Cited by 41 · see citing works
Yamada, D., Kawabe, K., Tosa, I., Tsukamoto, S., Nakazato, R., Kou, M., Fujikawa, K., Nakamura, S., Ono, M., Oohashi, T., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0582-4 · Cited by 38 · see citing works
Hương, L. T., Tran, N. T., Dao, T. M. L., Nguyen, D. D., Do, H. D., Ha, T. L., Kühn, R., Nguyễn, T. L., Rajewsky, K., & Chu, V. T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00625 · Cited by 38 · see citing works
“…of neurons but also important for the functions of glial subtypes in the brain as well as of many cell types in the immune system, including microglia and macrophages (Maezawa and Jin, 2010; Derecki et al., 2012; O’Driscoll et al., 2013; Cronk et al., 2015; Jin et al., 2015; Cronk et al., 2016).”
Background4-hydroxynonenal protein adducts: Key mediator in Rett syndrome oxinflammation
Valacchi, G., Pecorelli, A., Cervellati, C., & Hayek, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.045 · Cited by 37 · see citing works
Unexpected cellular players in Rett syndrome pathology
Cronk, J. C., Derecki, N. C., Litvak, V., & Kipnis, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.05.005 · Cited by 33 · see citing works
“To our surprise we found that Mecp2-null mice progressively lose microglia according to the severity of disease (Cronk et al., 2015), an observation also reported in another recent publication (Jin et al., 2015).”
BackgroundResultInfluentialUlk4 regulates GABAergic signaling and anxiety-related behavior
Liu, M., Fitzgibbon, M., Wang, Y., Reilly, J., Qian, X., O’Brien, T., Clapcote, S. J., Shen, S., & Roche, M. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0091-5 · Cited by 32 · see citing works
Komada, M., & Nishimura, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.852752 · Cited by 32 · see citing works
Recent advances in understanding synaptic abnormalities in Rett syndrome
Johnston, M. V., Blue, M. E., & Naidu, S. (2015) · F1000Research · doi:10.12688/f1000research.6987.1 · Cited by 30 · see citing works
Lv, Q.-Q., You, C., Zou, X., & Deng, H. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.06.027 · Cited by 29 · see citing works
Methyl-CpG Binding Protein 2 in Alzheimer Dementia
Kim, B., Choi, Y., Kim, H.-S., & Im, H. (2019) · International Neurourology Journal · doi:10.5213/inj.1938196.098 · Cited by 27 · see citing works
“However, although microglial MeCP2 knockdown directly caused NMDA receptor-dependent excitotoxic neuronal cell death [61], astrocytic MeCP2 deficiency did not affect the rate of neuronal cell death [62].”
BackgroundMaurya, S. K., Gupta, S., & Mishra, R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1072046 · Cited by 26 · see citing works
“Mecp2 regulates glutamate synthesis and mitochondria function in microglia by acting as a transcriptional repressor of the major glutamate transporter, SNAT1 (Jin et al., 2015).”
BackgroundSantos‐Terra, J., Deckmann, I., Fontes‐Dutra, M., Schwingel, G. B., Bambini-Júnior, V., & Gottfried, C. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10141 · Cited by 24 · see citing works
“, 2016), and metabolic alterations regarding glutamate uptake and ROS generation (Jin et al., 2015).”
BackgroundGolubiani, G., Lagani, V., Solomonia, R. O., & Müller, M. (2021) · Cells · doi:10.3390/cells10092494 · Cited by 24 · see citing works
“In support of these assumptions, increased energy expenditure and intensified ATP turnover were brought to light in neonatal hippocampal Mecp2−/y neurons [59], and a mitochondrial energy-wasting status has been proposed for RTT [60].”
BackgroundRett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
Bach, S., Shovlin, S., Moriarty, M. J., Bardoni, B., & Tropea, D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.764761 · Cited by 23 · see citing works
“…Whole cell patch clamp Loss of FMRP: ↑Cortical activity, ↑Locomotor activity, ↓Social novelty preference and memory acquisition deficits; Corrected by Fmr1 reactivation Jin et al., 2021 Fmr1−/y iPSC from patients with FXS differentiated into astrocytes RNA sequencing, immunocytochemistry.”
BackgroundThe Role of GABA Pathway Components in Pathogenesis of Neurodevelopmental Disorders
Marilovtseva, E. V., Abdurazakov, A., Kurishev, A. O., Mikhailova, V. A., & Голимбет, В. Е. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199492 · Cited by 20 · see citing works
“Importantly, upregulation of SLC38A1 due to the lack of methylation at its promoter was observed in peripheral blood in MDD [33] and in microglia in Rett syndrome [34].”
Fundamental Neurochemistry Review: Lipids across microglial states
Traetta, M. E., Vecchiarelli, H. A., & Tremblay, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16259 · Cited by 19 · see citing works
Proteomic analysis of the Rett syndrome experimental model mecp2Q63X mutant zebrafish.
Cortelazzo, A., Pietri, T., Felice, C. D., Leoncini, S., Guerranti, R., Signorini, C., Timperio, A., Zolla, L., Ciccoli, L., & Hayek, J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2016.12.010 · Cited by 19 · see citing works
Gonçalez, J. L., Shen, J., & Li, W. (2024) · Cells · doi:10.3390/cells13242077 · Cited by 19 · see citing works
“Increased SNAT1 activity within the glutamate synthesis pathway occurs due to a lack of MeCP2-mediated repression [103].”
Wittrahm, R., Takalo, M., Marttinen, M., Kuulasmaa, T., Mäkinen, P. M., Kemppainen, S., Martiskainen, H., Rauramaa, T. H., Pike, I., Leinonen, V., et al. (2021) · Cells · doi:10.3390/cells10040860 · Cited by 19 · see citing works
“Later, MECP2 has been found to act as a transcriptional repressor of the major glutamine transporter SNAT1 (also known as SLC38A1), leading to glutamate overproduction in Mecp2-null microglia [9].”
BackgroundMeCP2 in central nervous system glial cells: current updates
Sharma, K., Singh, J., Frost, E. E., & Pillai, P. P. (2018) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2018-007 · Cited by 18 · see citing works
“MeCP2 down regulation or SNAT1 over expression in microglia resulted in mitochondrial dysfunction and neurotoxicity due to overproduction of glutamate (Jin et al. 2015).”
BackgroundInfluenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice
Cronk, J. C., Herz, J., Kim, T. S., Louveau, A., Moser, E. K., Sharma, A. K., Smirnov, I., Tung, K. S. K., Braciale, T. J., & Kipnis, J. (2017) · JCI Insight · doi:10.1172/jci.insight.88257 · Cited by 16 · see citing works
Kawada, K., Kuramoto, N., & Mimori, S. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200319125109 · Cited by 17 · see citing works
Fagiolini, M., Patrizi, A., LeBlanc, J. J., Jin, L., Maezawa, I., Sinnett, S. E., Gray, S. J., Molholm, S., Foxe, J. J., Johnston, M. V., et al. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.037 · Cited by 17 · see citing works
“MeCP2 is expressed in microglia and related mononuclear phagocytes and regulates their functions, but the pathological role of microglia in RTT remains controversial (Maezawa and Jin, 2010; Derecki et al., 2012; Wang et al., 2015; Horiuchi et al., 2017; Schafer et al., 2016; Jin et al., 2015; Cronk et al., 2015).”
BackgroundResultZhang, Z., Huang, S., Wang, Y., Jiang, Z., Liu, Z., Wang, C., Ji, R., Yuan, Y., Mao, X., Yang, K., et al. (2025) · Advanced Science · doi:10.1002/advs.202513400 · Cited by 16 · see citing works
Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome
Musokhranova, U., Grau, C., Vergara, C., Rodríguez‐Pascau, L., Xiol, C., Castells, A. A., Alcántara, S., Rodríguez‐Pombo, P., Pizcueta, P. M., Martinell, M., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04622-5 · Cited by 17 · see citing works
“This agrees with studies that reported a decrease in brain ATP synthesis [33–35], but while knowledge was mostly limited to whole brain analysis, we have studied bioenergetic function both between different brain areas and at two different time-points through the phenotype progression.”
ResultAltered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome
Smith, E. S., Smith, D. R., Eyring, C., Braileanu, M., Smith-Connor, K., Tan, Y. E., Fowler, A., Hoffman, G. E., Johnston, M. V., Kannan, S., et al. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.11.007 · Cited by 16 · see citing works
“Mecp2-null microglia also contributed to these pathologically high extracellular glutamate levels by upregulation of glutaminase and the glutamine transporter SNAT1 (Jin et al., 2015; Maezawa & Jin, 2010).”
BackgroundDave, A. R., Shukla, F., Wala, H., & Pillai, P. P. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1197-9 · Cited by 17 · see citing works
“…genes, proteins, and enzyme activities, and reduced ATP level have also been documented in RTT condition (Kriaucionis et al. 2006; Pecorelli et al. 2013; Gold et al. 2014; Valenti et al. 2017; De Filippis et al. 2015; Li et al. 2013; Saywell et al. 2006; Gibson et al. 2010; Jin et al. 2015).”
BackgroundBlood–Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome
Pepe, G., Fioriniello, S., Marracino, F., Capocci, L., Maglione, V., D’Esposito, M., Pardo, A. D., & Ragione, F. D. (2023) · Biomolecules · doi:10.3390/biom13040606 · Cited by 14 · see citing works
“Of note, previous in vitro studies suggested that microglia from Mecp2-/y mice are responsible for the over-production of glutamate [70], which exerts a neurotoxic effect on dendrites and synapses [70,71].”
BackgroundRIPK1 activation in Mecp2-deficient microglia promotes inflammation and glutamate release in RTT
Cao, Z., Min, X., Xie, X., Huang, M., Liu, Y., Sun, W., Xu, G., He, M., He, K., Li, Y., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320383121 · Cited by 14 · see citing works
“Upregulated SNAT1 (encoded by the gene SLC38A1) and glutaminase (GLS) proteins in microglia of Mecp2 - null male have been reported to contribute to the superfluous glutamates release under the Mecp2 - deficient condition and contribute to neurotoxicity (36, 37).”
Human microglial cells as a therapeutic target in a neurodevelopmental disease model
Mesci, P., LaRock, C. N., Jeziorski, J. J., Nakashima, H., Chermont, N., Ferrasa, A., Herai, R. H., Ozaki, T., Saleh, A., Snethlage, C. E., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.06.013 · Cited by 13 · see citing works
MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome
Ciernia, A. V., Yasui, D. H., Pride, M. C., Durbin-Johnson, B. P., Noronha, A. B., Chang, A., Knotts, T. A., Rutkowsky, J. M., Ramsey, J. J., Crawley, J. N., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy301 · Cited by 13 · see citing works
“elevated lactate and pyruvate in blood and cerebral spinal fluid (26), as well as markers of oxidative damage (27) that are also seen in mouse models (28, 29).”
BackgroundMetabolic Flexibility of Microglia: Energy Substrate Utilization and Impact on Neuronal Metabolism
Westi, E. W., Carlsen, R. B., Andersen, J. V., Kilic, Z., Alnajar, D., Holmgaard, N. K., Sintes, B. G., Cota-Coronado, A., Muñoz, S. S., Galvagnion, C., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70304 · Cited by 12 · see citing works
“However, microglia express the glutamine transporter SNAT1 (Jin et al. 2015; Yamada et al. 2019) and possess the necessary cellular machinery to me-tabolize glutamine (Bernier, York, Kamyabi, et al. 2020).”
Choi, G. T., Lee, S., Yoo, S., & Tae, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178277 · Cited by 10 · see citing works
“In neurons and glial cells of Rett syndrome cerebral organoids, mitochondrial length and area were reduced compared to those in the control group, and the alteration was particularly significant in glial cells [205–207].”
Khoury, E. S., Patel, R. V., O’Ferrall, C., Fowler, A., Sah, N., Sharma, A., Gupta, S. S., Scafidi, S., Kurtz, J. S., Olmstead, S. J., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15960 · Cited by 10 · see citing works
Liempd, S. M. V., Cabrera, D., Lee, F. Y., González, E., Dell’Angelica, E. C., Ghiani, C. A., & Falcón‐Pérez, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05465-z · Cited by 10 · see citing works
Dendrites in Autism Spectrum Disorders
Martínez‐Cerdeño, V., Maezawa, I., & Jin, L. (2016) · Springer eBooks · doi:10.1007/978-4-431-56050-0_20 · Cited by 8 · see citing works
“Strong evidence suggests that microglia could be a common effector in RTT, supporting the microglia hypothesis discussed above (Maezawa and Jin 2010; Derecki et al. 2012; Jin et al. 2015).”
BackgroundAdvances in the pathogenesis of Rett syndrome using cell models
Lü, S., Chen, Y., & Wang, Z. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12236 · Cited by 7 · see citing works
MeCP2 in the regulation of neural activity: Rett syndrome pathophysiological perspectives
Percy, A. K., Cuddapah, V. A., Nwaobi, S. E., & Olsen, M. L. (2015) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s61269 · Cited by 8 · see citing works
“92 Upregulation of the transporter was sufficient to increase glutamine uptake and glutamate production and induce toxicity in microglia secondary to the elevated glutamine levels.”
Dave, A. R., & Pillai, P. P. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23002 · Cited by 7 · see citing works
The impact of mild episodic ketosis on microglia and hippocampal long‐term depression in 5xFAD mice
Lucente, J. D., Ramsey, J. J., Jin, L., & Maezawa, I. (2024) · FASEB BioAdvances · doi:10.1096/fba.2024-00123 · Cited by 6 · see citing works
Jayasooriya, R. G. P. T., Molagoda, I. M. N., Dilshara, M. G., Choi, Y. H., & Kim, G. (2020) · Antioxidants · doi:10.3390/antiox9060536 · Cited by 5 · see citing works
“This discrepancy was caused by the imbalance of Gln/Glu ratios and deregulation of Gln homeostasis, resulting in mitochondrial dysfunction and microglial neurotoxicity [9].”
BackgroundNakisli, S., Fanelli, K., LaComb, J., Arnold, L. J., & Nielsen, C. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-86150-4 · Cited by 4 · see citing works
“Our experiments also showed increased of expression of Snat1 , which encodes a microglial-specific glutamine transporter and is required for glutamine metabolism 43 .”
Central respiratory command and microglia: An early-life partnership
Thoby‐Brisson, M. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102756 · Cited by 1 · see citing works
Dreux, V., Lefebvre, C., Breemeersch, C.-E., Tiffay, A., Déchelotte, P., Goichon, A., Langlois, L. D., & Coëffier, M. (2026) · Inflammation · doi:10.1007/s10753-025-02428-9 · Cited by 1 · see citing works
“However, mice with an overexpression of the glutamine transporter SLC38A1 constitutively produced and excreted glutamate into the interstitial space, resulting in neurotoxicity [18 ].”
Vitorino, M., Conceição, N., & Cancela, M. L. (2018) · Journal of Applied Ichthyology · doi:10.1111/jai.13667 · Cited by 1 · see citing works
Zelenka, L., Jarek, M., Pägelow, D., Geffers, R., van Vorst, K., & Fulde, M. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.05.001 · Cited by 1 · see citing works
Metabolic reprogramming supports microglial survival and immune function
York, E. M. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0379730
Metabolic Therapy for Autism Spectrum Disorder and Comorbidities
Cheng, N., Masino, S. A., & Rho, J. M. (2016) · doi:10.1093/med/9780190497996.003.0014
Role of Gut Microbiota in the Developmental Regression of AutismPreprint
Cui, J. J., Li, H., Hu, C., Wu, D., Li, H., Luo, X., & Hao, Y. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4627113
Musokhranova, U., Grau, C., Vergara, C., Rodríguez‐Pascau, L., Xiol, C., Castells, A. A., Alcántara, S., Rodríguez‐Pombo, P., Pizcueta, P. M., Martinell, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26632621
Sleep-wake regulation by Palladin via the blood-brain-barrier
Li, H. (2022) · theses.fr (ABES) · doi:10.70675/6142554dzdf7dz4640z8c76ze90c5609291d
Toward an NGF-based therapy for Rett syndrome
Borgonovo, G., Tiberi, A., Capsoni, S., & Cattaneo, A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1800227
“A decade ago, molecular mechanisms were identified linking MeCP2 to the regulation of bioenergetic pathways in microglia (Jin et al., 2015).”
A high-throughput screening platform to facilitate treatment development in Rett syndrome
Yin, Y., Wang, A., Dong, Q., ZHANG, Z., Bu, Q., Wang, R., & Chang, Q. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1759410
- Authors
- Jin, L.-W., Horiuchi, M., Wulff, H., Liu, X.-B., Cortopassi, G. A., Erickson, J. D., & Maezawa, I.
- Affiliations
- University of California Davis Medical Center (US)
- University of California, Davis (US)
- Louisiana State University (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2015-02-11
- Volume
- 35
- Issue
- 6
- Pages
- 2516-2529
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4323531
- OpenAlex
- W2092719082
- Cited by
- 88
- References
- 71
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 4 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 7 · 2015: 3
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (GM076063)
- National Institute of General Medical Sciences (GM076063, R01GM076063)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD079125, HD073631, R01HD064817, R21HD073631, HD064817)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Rett syndrome, MeCP2, SNAT1, SLC38A1, glutamine transporter, microglia, mitochondrial dysfunction, reactive oxygen species, catalase, mitochondria-targeted antioxidants, transcriptional repression, Mecp2 knockout mice
- MeSH terms
- Adenosine Triphosphate, Animals, Glycine, Mice, Inbred C57BL, Oxygen Consumption, Rett Syndrome, Microglia, Mice, Knockout, Glutamic Acid, Neurotoxicity Syndromes, Amino Acid Transport System A, Mitochondrial Diseases, Mice, Methyl-CpG-Binding Protein 2, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review